This year J.P. Morgan 39th Annual Healthcare Conference was conducted virtually and we witnessed multiple announcements from numerous Biopharma companiesAn analysis of events and catalysts that were announced at the conference during these days are included in the report. Most of the deals occurred in the first two days of the conferenceOur PharmaShots…
The year 2019 has been a busy year for global pharma and biotech companies involved in M&A, option & licensing agreements and gaining approvals. Our team has compiled a list of 20 most read life sciences news on PharmaShots in 2019.1. Celltrion Signed an Exclusive Co-Marketing Agreement with Juno in AustraliaJuno provided sales promotion…
The first quarter of 2019 has marked with major events in the pharma & biotech industries. We have gathered the key highlights of the quarter, which was starting with the blockbuster news, where Celgene had acquired BMS for $74B. Moving to the next news, acquisition of Loxo Oncology for $8B, in addition to Spark Therapeutics…

